Centre Georges-François Leclerc, Department of Medical Oncology

Dijon 21000

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Cancer, Solid Tumor

Studies at this site

• Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies — Completed